Immuno-Oncology

Featured

News
ACCC Releases Report on Current State of Immuno-Oncology
The report highlights current research, utilization trends, and coming advances for immunotherapies.
News
Refining Selection Criteria for Immune Checkpoint Inhibitors in Recurrent Ovarian Cancer
A new report shed light on the utility of BRCA mutations, tumor mutation burden, and homologous DNA repair deficiency…
News
Real-World Costs of Adverse Events After First-Line Treatment of Metastatic NSCLC
Patients receiving immunotherapy have lower adverse event-related costs than those receiving cytotoxic chemotherapy for…
News
Post-HSCT Immunosuppression Improves Outcomes in AML
Patients with AML who receive a checkpoint inhibitor prior to transplant and then an immunosuppressive chemotherapy…
News
Real-World Financial Toxicity in Patients Receiving Cancer Immunotherapy
Results of a survey presented at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium shed light on the extent of…

News

ACCC Releases Report on Current State of Immuno-Oncology
Refining Selection Criteria for Immune Checkpoint Inhibitors in Recurrent Ovarian Cancer
Real-World Costs of Adverse Events After First-Line Treatment of Metastatic NSCLC
Post-HSCT Immunosuppression Improves Outcomes in AML

Guideline Updates

NCCN Releases Update on Management Recommendations for Immunotherapy-Related Toxicities

Conference Coverage

ASCO-SITC Clinical Immuno-Oncology Symposium